Eric Francis Yves Thepaut is President & VP at BOSTON SCIENTIFIC CORP (BSX). They have made 13 open-market trades across 1 company since 2017, most recently 2024-05-10.
CIK 0001631992
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSX | 31,421 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2024-05-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BSX | SELL | 2024-05-10 | 2024-05-13 | $74.14 | $1.9M | +2.5% | +6.6% | +4.6% |
| BSX | SELL | 2023-05-02 | 2023-05-03 | $52.49 | $8.8M | +2.4% | -1.2% | -1.0% |
| BSX | SELL | 2022-11-18 | 2022-11-21 | $42.72 | $1.3M | +8.3% | +7.1% | +7.4% |
| BSX | SELL | 2022-08-01 | 2022-08-03 | $40.99 | $1.7M | +1.2% | -2.8% | +2.6% |
| BSX | SELL | 2021-08-05 | 2021-08-06 | $44.14 | $3.7M | -1.4% | +0.9% | -4.9% |
| BSX | SELL | 2021-02-12 | 2021-02-17 | $38.65 | $2.2M | +4.3% | +2.4% | +12.0% |
| BSX | SELL | 2019-11-26 | 2019-11-27 | $42.70 | $1.9M | +2.0% | +4.8% | -7.5% |
| BSX | SELL | 2019-05-29 | 2019-05-30 | $38.03 | $1.7M | +7.9% | +12.4% | +11.3% |
| BSX | SELL | 2019-02-27 | 2019-02-28 | $39.94 | $957K | -0.5% | -4.5% | -6.0% |
| BSX | SELL | 2018-11-29 | 2018-12-03 | $36.74 | $1.1M | -7.1% | -10.6% | +4.6% |
| BSX | SELL | 2018-11-09 | 2018-11-13 | $37.51 | $1.8M | -5.0% | +0.3% | +6.6% |
| BSX | SELL | 2018-05-17 | 2018-05-18 | $30.15 | $1.2M | -0.5% | +5.7% | +12.2% |
| BSX | SELL | 2017-02-06 | 2017-02-08 | $24.94 | $1.2M | +0.2% | -2.4% | +4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.